Ager, C. R., Zhang, M., Chaimowitz, M., Bansal, S., Tagore, S., Obradovic, A., Jugler, C., Rogava, M., Melms, J. C., McCann, P., Spina, C., Drake, C. G., Dallos, M. C., & Izar, B. (2023). KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response. Journal for ImmunoTherapy of Cancer, 11(9), e006782. https://doi.org/10.1136/jitc-2023-006782
Columbia Affiliation:
Subjects:
Carcinoma, Renal Cell
(MeSH)
Kidney Neoplasms
(MeSH)
Cancer Immunotherapy
(OpenAlex Topic)
Chimeric Antigen Receptor T Cell Therapy
(OpenAlex Topic)
Immunobiology of Dendritic Cells
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1136/jitc-2023-006782
PMID:
Journal:
Publication Date:
Data Source:
OpenAlex
Source Link: